Oxcarbazepine Tablet, Film Coated
Product Images NDC 60687-733

14 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 60687-733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp71101

Ahp71101
Oxcarbazepine 150 mg film-coated tablet. The oblong, brown tablet is embossed with 'V' on one side and '7 6' split by a score on the other side. This oral tablet is manufactured by American Health Packaging.*
FDA Label Image

Ahp72201

Ahp72201
Oxcarbazepine 150 mg film-coated oral tablet, light brown, capsule-shaped with a score line. One side imprinted with "A" and the other side imprinted with "77". Manufactured by American Health Packaging.*
FDA Label Image

Ahp73301

Ahp73301
Oxcarbazepine 150 mg film-coated tablet, oral dosage form. The brown, oblong tablet is scored and imprinted on one side with the letter 'V' and on the other side with the numbers '7 8'. Labeled by American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of oxcarbazepine, showing the molecular arrangement including two aromatic rings, a seven-membered ring with a ketone group, and an amide functional group attached to a nitrogen atom.*
FDA Label Image

Figure 1: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure1)

Figure 1: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure1)
A Kaplan-Meier survival plot showing exit rates over time in days from Day 2 to Day 11 at 8 am, comparing Oxcarbazepine treatment group (solid line) with Placebo group (dotted line). The y-axis represents the exit rate from 0.0 to 1.0. The chart includes a log-rank test p-value: 0.0001.*
FDA Label Image

Figure 2: Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group (Figure2)

Figure 2: Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group (Figure2)
A Kaplan-Meier plot depicting seizure rate over time from first dose to first seizure, comparing treatment groups Oxcarbazepine and placebo. The x-axis shows days, and the y-axis shows seizure rate. The plot includes a log-rank test with a p-value of 0.046, indicating statistical analysis of the difference between groups.*
FDA Label Image

Figure 3: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure3)

Figure 3: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure3)
A Kaplan-Meier curve comparing exit rates over time in days between two treatment groups labeled HIGH (solid line) and LOW (dashed line). The y-axis represents the exit rate from 0 to 1.0, and the x-axis shows time to exit up to 130 days. A log-rank test reports a p-value of 0.0001, indicating statistical significance between groups.*
FDA Label Image

Figure 4: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure4)

Figure 4: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure4)
A Kaplan-Meier survival curve chart showing the exit rate over time (days) for two treatment groups labeled HIGH and LOW. The LOW group (dotted line) has a higher exit rate over time compared to the HIGH group (solid line). The chart includes a log-rank test p-value of 0.0001 indicating statistical significance.*
FDA Label Image

150 mg Oxcarbazepine Tablets Carton (150 mg Oxcarbazepine Tablets Carton)

150 mg Oxcarbazepine Tablets Carton (150 mg Oxcarbazepine Tablets Carton)
Label for Oxcarbazepine Tablets, USP, 150 mg oral film-coated tablets. The label indicates a package containing 100 tablets (10 x 10) and shows the National Drug Code (NDC) 60687-711-01. It includes storage instructions, a pharmacist dispensing note, and distribution information by American Health Packaging, Columbus, Ohio. A QR code for medication guide and prescribing information is also visible.*
FDA Label Image

150 mg Oxcarbazepine Tablet Blister (150 mg Blister 01)

150 mg Oxcarbazepine Tablet Blister (150 mg Blister 01)
Multiple identical labels for Oxcarbazepine 150 mg film-coated tablets. Each label includes the product name, dosage strength, barcode, and fields for expiry date and lot number. The labels also display the labeler information: American Health Packaging, Columbus, Ohio 43217.*
FDA Label Image

300 mg Oxcarbazepine Tablets Carton (300 mg Oxcarbazepine Tablets Carton)

300 mg Oxcarbazepine Tablets Carton (300 mg Oxcarbazepine Tablets Carton)
Oxcarbazepine 300 mg film-coated tablets in a package containing 100 tablets (10 x 10) labeled for oral use. The label includes the NDC number 60687-722-01 and states that the drug is Rx only. It instructs pharmacists to dispense with the Medication Guide. The label also provides storage instructions and manufacturer information, indicating it is distributed by American Health Packaging.*
FDA Label Image

300 mg Oxcarbazepine Tablet Blister (300 mg Blister 01)

300 mg Oxcarbazepine Tablet Blister (300 mg Blister 01)
Labels for Oxcarbazepine tablet, USP 300 mg by American Health Packaging. Each label includes the product name, strength of 300 mg, dosage form as tablet, and identifying barcodes. The labels also show placeholder text for expiration date and lot number.*
FDA Label Image

600 mg Oxcarbazepine Tablets Carton (600 mg Oxcarbazepine Tablets Carton)

600 mg Oxcarbazepine Tablets Carton (600 mg Oxcarbazepine Tablets Carton)
Oxcarbazepine 600 mg film-coated tablets in a package of 100 tablets (10 x 10) manufactured by American Health Packaging. The label includes the product's NDC 60687-733-01 and instructions to dispense with medication guide. Storage conditions and safety warnings for blister use are noted, along with distributor information for American Health Packaging, Columbus, Ohio.*
FDA Label Image

600 mg Oxcarbazepine Tablet Blister (600 mg Blister 01)

600 mg Oxcarbazepine Tablet Blister (600 mg Blister 01)
This image shows a blister card containing ten tablets of Oxcarbazepine, 600 mg film-coated tablets. Each tablet is individually sealed in the blister with labeling that includes the product name, strength, dosage form, a barcode, expiration date placeholder, lot number placeholder, and American Health Packaging as the labeler. The tablets are intended for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.